Given its diverse roles across cancers, strategies aimed at modulating GABARAP activity, either inhibiting its tumor-supportive functions or exploiting its capacity to induce lethal stress responses, may offer translational opportunities in osteosarcoma and other malignancies. Here, GABARAP is linked to neoplasm.